Source: PharmiWeb

Cingulate Therapeutics: Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments

Cingulate Therapeutics Strengthens Leadership with Two New Board AppointmentsKANSAS CITY, Kan.Cingulate Therapeutics

Read full article »
Cingulate Therapeutics's Competitors | Cingulate Therapeutics's News | Cingulate Therapeutics's Financials
Stay up-to-date with the latest news on Cingulate Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Shane J. Schaffer's photo - Chairman & CEO of Cingulate Therapeutics

Chairman & CEO

Shane J. Schaffer

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Cingulate Therapeutics